Long-Acting Antiretroviral Therapy for HIV via Drop-in Community-Based Care - Report - MDSpire

Long-Acting Antiretroviral Therapy for HIV via Drop-in Community-Based Care

  • By

  • Nicky J. Mehtani

  • Stephen J. Matzat

  • Kathleen B. O’Connor

  • Laura Cordoba

  • Sarah Strieff

  • Alix Strough

  • Morgan M. Philbin

  • Mallory O. Johnson

  • Monica Gandhi

  • Barry Zevin

  • June 26, 2026

  • 0 min

Share

Community-Based Approaches to Long-Acting Antiretroviral Treatment for HIV

Background

Individuals experiencing homelessness (PEH) in the US have a significantly higher HIV prevalence compared to the general population, coupled with lower rates of viral suppression. Structural and psychosocial barriers contribute to challenges in adhering to oral antiretroviral therapy (ART). Long-acting ART (LA-ART) presents a potential solution, yet its implementation in community-based settings remains underexplored.

Data Highlights

No numerical data available in the provided source material.

Key Findings

  • LA-ART has been shown to be effective in patients with viremia facing challenges to oral ART adherence.
  • The MXM Health Resource Center serves a diverse population of PEH, with a significant proportion identifying as Black or Hispanic/Latine.
  • Eligibility for LA-ART was streamlined to enhance access for individuals with housing instability and substance use issues.
  • Prior studies have established the safety and efficacy of LA-ART, but most were conducted in specialty settings.
  • Recent updates to guidelines support the use of LA-ART for select individuals with HIV viremia and adherence barriers.

Clinical Implications

The findings suggest that community-based clinics can effectively implement LA-ART for individuals experiencing homelessness, addressing significant barriers to care. This approach may improve treatment adherence and viral suppression among this vulnerable population.

Conclusion

The integration of LA-ART in community settings like the MXM Health Resource Center represents a critical step in addressing HIV treatment disparities among individuals experiencing homelessness.

Related Resources & Content

  1. JAMA Network Open, 2024 -- Homelessness and HIV Treatment Among Men Who Have Sex With Men Across US Funding Contexts
  2. Open Forum Infectious Diseases, 2024 -- Unintentional Lenacapavir Monotherapy Leading to HIV Viral Suppression in Patients with Adherence Difficulties: A Case Series
  3. JAMA Network Open, 2024 -- Long-Acting Injectable Antiretroviral Therapy in Medicare-Enrolled Adults With HIV
  4. Long-Acting HIV Medicine | NIH, 2026
  5. Open Forum Infectious Diseases — Streamlined Hepatitis C Virus Testing and Treatment Protocol for Homeless Individuals Who Inject Drugs
  6. Long-Acting HIV Medicine | NIH
  7. Cabotegravir/Rilpivirine for Persons with HIV and Adherence Challenges - PMC
  8. https://www.croiconference.org/wp-content/uploads/sites/2/posters/2025/691-2025.pdf
  9. Ryan White Program Moving Forward | Ryan White HIV/AIDS Program

Original Source(s)

Related Content